project id: TCGA-ESCA; case submitter id: TCGA-IG-A6QS; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.2; age at index: 54; days to birth: -19900; days to death: 303; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1959; age at diagnosis: 19900; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 1.8630136986301369; pack years smoked: 34.0; is ffpe: false; composition: Not Reported; days to collection: 173; days to sample procurement: 0; initial weight: 770.0; portion submitter id: TCGA-IG-A6QS-01A-12; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;